Log in to save to my catalogue
Log in to save to my catalogue

Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future...

| Ask | Become a Library member

Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956679

Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials

About this item

Full title

Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials

Author / Creator

Sharma, Ashish , Kumar, Nilesh , Parachuri, Nikulaa , Karanam, Dhatri , Kuppermann, Baruch D. , Bandello, Francesco and Regillo, Carl D.

Publisher

London: Nature Publishing Group UK

Journal title

Eye (London), 2022-04, Vol.36 (4), p.679-680

Language

English

Formats

Articles

Publication information

Publisher

London: Nature Publishing Group UK

Subjects

More information

Alternative Titles

Full title

Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956679

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8956679

Other Identifiers

ISSN

0950-222X

E-ISSN

1476-5454

DOI

10.1038/s41433-021-01831-4

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections